Sponsor:
Blueprint Medicines Corporation
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-11. This information was provided to ClinicalTrials.gov by Blueprint Medicines Corporation on 2025-04-30.